Abstract
Cavernous angiomas are vascular malformations mostly located in the central nervous system and characterized by enlarged capillary cavities without intervening brain parenchyma1. Clinical symptoms include seizures, haemorrhage and focal neurological deficits. Cavernous angiomas prevalence is close to 0.5% in the general population2. They may be inherited as an autosomal dominant condition in as much as 50% of cases3. Cerebral cavernous malformations (CCM) loci were previously identified on 7q, 7p and 3q (refs 4,5). A strong founder effect was observed in the Hispano-American population, all families being linked to CCM1 on 7q (refs 4,7). CCM1 locus assignment was refined to a 4-cM interval bracketed by D7S2410 and D7S689 ( ref. 8). Here we report a physical and transcriptional map of this interval and that CCM1, a gene whose protein product, KRIT1, interacts with RAP1A (also known as KREV1; ref. 9), a member of the RAS family of GTPases, is mutated in CCM1 families. Our data suggest the involvement of the RAP1A signal transduction pathway in vasculogenesis or angiogenesis10.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Russell, D.S. & Rubenstein, L.J. Pathology of Tumours of the Nervous System 730–736 (Williams and Wilkins, Baltimore, 1989).
Otten, P., Pizzolato, G.P., Rilliet, B. & Berney, J. A propos de 131 cas d'angiomes caverneux (cavernomes) du SNC, repérés par l'analyse rétrospective de 24 535 autopsies. Neurochirurgie 35, 82–83 ( 1989).
Rigamonti D. et al. Cerebral cavernous malformations. Incidence and familial occurence. N. Engl. J. Med. 319, 343– 347 (1988).
Dubovsky, J. et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum. Mol. Genet. 4, 453–458 (1995).
Craig, H.D. et al. Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15–13 and 3q25.2–27. Hum. Mol. Genet. 7, 1851– 1858 (1998).
Günel, M. et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N. Engl. J. Med. 334, 946–951 (1996).
Günel, M. et al. Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery 38, 1265– 1271 (1996).
Johnson, E.W. et al. Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4 cM interval of chromosome 7q contained in a well-defined YAC contig. Genome Res. 5, 368– 380 (1995).
Serebriiskii, I. et al. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21–22. Oncogene 15, 1043–1049 (1997).
Bos, J.L. All in the family? New insights and questions regarding interconnectivity of ras, rap1 and raI. EMBO J. 17, 6776– 6782 (1998).
Labauge, P. et al. Hereditary cerebral cavernous angiomas, clinical and genetic features in 57 French families. Lancet 352, 1892–258 (1998).
Laberge, S., Labauge, P., Maréchal, E., Maciazek, J. & Tournier-Lasserve, E. Genetic heterogeneity and absence of founder effect in a series of 36 non Hispano-American cerebral cavernomas families. Eur. J. Hum. Genet. 7, 499–504 (1999).
Benson, D.A. et al. GenBank. Nucleic Acids Res. 27, 12– 17 (1999).
Pizon, V., Chardin, P., Lerosey, I., Olofsson, B. & Tavitian, A. Human cDNAs rap 1 and rap2 homologous to the Drosophilia gene Dras3 encode proteins closely related to ras in the effector region. Oncogene 3, 201–204 (1988).
Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. & Noda, M. A ras-related gene with transformation suppressor activity. Cell 56, 77– 84 (1989).
Henkemeyer, M. et al. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377, 695–701 (1995).
Wojnowski, L. et al. Endothelial apoptosis in Braf-deficient mice. Nature Genet. 16, 293–297 (1997).
Asha, H., de Ruiter, N.D., Wang, M.G. & Hariharan, I.K. The Rap1 GTPase functions as a regulator of morphogenesis in vivo. EMBO J. 18, 605–615 ( 1999).
Quarck, R. et al. Differential up-regulation of Rap1a and Rap1b proteins during smooth muscle cell cycle. Eur. J. Cell Biol. 70, 269–277 (1996).
Pizon, V, Cifuentes-Diaz, C., Mege, R.M., Baldacci, G. & Rieger, F. Expression and localization of rap1 proteins during myogenic differentiation. Eur. J. Cell Biol. 69, 224–235 ( 1996).
Altschul, S.F. et al. Gapped BLAST and PSI-BLAST, a new generation of protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
Huang, X., Adams, M.D., Zhou, H. & Kerlavage, A.R. A tool for analysing and annotating genomic sequences. Genomics 46, 37–45 (1997).
Acknowledgements
We thank all members of the Societe Francaise de Neurochirurgie, in particular, L. Capelle, J.P. Castel, D. Fohano, B. George, J. Philippon, A. Rey and F. Roux, this study would not have been possible without their help; F. Chapon for pathological advice and the families for their participation. S.L.L.C. had a studentship from the Fonds de la Recherche en Santé du Québec (FRSQ, Canada). P.L. had a poste d'accueil INSERM and H.H.J. had a fellowship from the Schweizerishe Stiftung fûr Medizinisch-Biologische Stipendien. This work was supported by INSERM, Ministère de l'Enseignement Supérieur et de la Recherche (MESR, ACCSV 1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Couteulx, Sl., Jung, H., Labauge, P. et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23, 189–193 (1999). https://doi.org/10.1038/13815
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/13815